Related Experiment Video
Updated: May 27, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications
O Mir1, R Coriat1, P Boudou-Rouquette1
1Centre for Research on Angiogenesis Inhibitors (CERIA), Université Paris Descartes, Sorbonne Paris Cité, Cochin Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
No abstract available in PubMed .
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
